Utility of Sentinel Flaps in Assessing Facial Allograft Rejection

Background: Skin biopsies are critical for histologic evaluation of rejection and proper treatment after facial allotransplantation. Many facial allografts provide only limited skin area, and frequent biopsies may also compromise aesthetic outcome. Sentinel flaps, recovered as free fasciocutaneous radial forearm flaps, have been used for remote-site rejection monitoring. They maintain their axial blood supply, similar to facial allografts. The correlation between facial allografts and sentinel flaps in cases of rejection is presented. Methods: The authors analyzed the experience of the Boston team’s use of four sentinel flaps. Rejection was evaluated and results were compared for each time point. Sentinel flaps were used as functional flaps whenever possible. Results: Results showed a reliable correlation between biopsy specimens taken from the facial allograft and sentinel flaps. During severe rejection episodes in 100 percent of biopsy pairs, both sites displayed a similar grade of rejection. In one case, clinical findings suggested rejection in the facial allograft but were unraveled as rosacea, because clinically there was no rejection displayed in the sentinel flap. Conclusions: The sentinel flap shows a reliable correlation to the facial allograft in cases of severe rejection, therefore providing a valuable tool for rejection monitoring in facial allotransplantation. Advantages of using these flaps include the avoidance of further surgical procedures to the primary vascularized composite allotransplant, additional use of the sentinel flap to repair damaged nonfacial sites, and its utility as both a clinical and histopathologic barometer of rejection and predictor of the potential existence of facial dermatitis unrelated to rejection. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, IV.

[1]  B. Pomahac,et al.  Facial and hand allotransplantation. , 2014, Cold Spring Harbor perspectives in medicine.

[2]  Amir H Dorafshar,et al.  Aesthetic and Functional Facial Transplantation: A Classification System and Treatment Algorithm , 2014, Plastic and reconstructive surgery.

[3]  C. Lian,et al.  Biomarker evaluation of face transplant rejection: association of donor T cells with target cell injury , 2014, Modern Pathology.

[4]  B. Pomahac,et al.  Evolution of Ethical Debate on Face Transplantation , 2013, Plastic and reconstructive surgery.

[5]  Blake D. Murphy,et al.  Vascularized composite allotransplantation: an update on medical and surgical progress and remaining challenges. , 2013, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.

[6]  B. Pomahac,et al.  Split Rejection in Vascularized Composite Allotransplantation , 2013, Eplasty.

[7]  S. Khalifian,et al.  A Critical Analysis of Rejection in Vascularized Composite Allotransplantation: Clinical, Cellular and Molecular Aspects, Current Challenges, and Novel Concepts , 2013, Front. Immunol..

[8]  Geoffroy C. Sisk,et al.  Vascularized composite tissue allotransplantation – state of the art , 2013, Clinical transplantation.

[9]  Jean Kanitakis,et al.  Standardizing skin biopsy sampling to assess rejection in vascularized composite allotransplantation , 2013, Clinical transplantation.

[10]  X. Zheng,et al.  Site-Specific Immunosuppression in Vascularized Composite Allotransplantation: Prospects and Potential , 2013, Clinical & developmental immunology.

[11]  X. Zheng,et al.  Review of the Early Diagnoses and Assessment of Rejection in Vascularized Composite Allotransplantation , 2013, Clinical & developmental immunology.

[12]  O. Guntinas-Lichius,et al.  Three patients with full facial transplantation. , 2012, The New England journal of medicine.

[13]  S. Testelin,et al.  First Human Face Transplantation: 5 Years Outcomes , 2012, Transplantation.

[14]  B. Pomahac,et al.  Facial Composite Tissue Allograft , 2012, The Journal of craniofacial surgery.

[15]  B. Pomahac,et al.  Evolution of indications for facial transplantation. , 2011, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.

[16]  B. Pomahac,et al.  Transmission of Donor‐Specific Skin Condition From Donor to Recipient of Facial Allograft , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[17]  W. Morrison Face transplantation , 2009, ANZ journal of surgery.

[18]  A. Kirk,et al.  The Banff 2007 Working Classification of Skin‐Containing Composite Tissue Allograft Pathology , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[19]  A. Sirigu,et al.  Outcomes 18 months after the first human partial face transplantation. , 2007, The New England journal of medicine.

[20]  G. Hofmann,et al.  Outcome of allogeneic vascularized knee transplants , 2007, Transplant international : official journal of the European Society for Organ Transplantation.

[21]  S. Testelin,et al.  Clinicopathologic Monitoring of the Skin and Oral Mucosa of the First Human Face Allograft: Report on the First Eight Months , 2006, Transplantation.

[22]  S. Gruber,et al.  The case for local immunosuppression in composite tissue allotransplantation. , 1998, Transplantation proceedings.

[23]  J. Anthony,et al.  A LONG‐TERM STUDY OF ALLOGENEIC RAT HINDLIMB TRANSPLANTS IMMUNOSUPPRESSED WITH RS‐61443 , 1993, Transplantation.

[24]  F W Pirruccello,et al.  Plastic and reconstructive surgery. , 1967, IMJ. Illinois medical journal.